In a regulatory filing on Friday, Janux Therapeutics (JANX) disclosed that its CEO David Campbell sold 25K shares of common stock on December 24th in a total transaction size of $1.4M.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JANX:
- Janux Therapeutics 5.32M share Secondary priced at $63.00
- Salesforce up after Q3, GM outlines $5B in China business charges: Morning Buzz
- Janux Therapeutics announces $300M common stock offering
- AT&T announces long-term targets, BlackRock acquires HPS: Morning Buzz
- Morning Movers: U.S. Steel falls following Trump vow to block Nippon deal